as 05-20-2024 4:00pm EST
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | BILLERICA |
Market Cap: | 11.3B | IPO Year: | 2000 |
Target Price: | $85.71 | AVG Volume (30 days): | 955.3K |
Analyst Decision: | Buy | Number of Analysts: | 8 |
Dividend Yield: | 0.26% | Dividend Payout Frequency: | Quarterly |
EPS: | 2.74 | EPS Growth: | 30.48 |
52 Week Low/High: | $53.79 - $94.86 | Next Earning Date: | 05-02-2024 |
Revenue: | $3,000,900,000 | Revenue Growth: | 14.49% |
Revenue Growth (this year): | 12.23% | Revenue Growth (next year): | 7.03% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Busse Falko | BRKR | PRESIDENT, BIOSPIN GROUP | Feb 28 '24 | Sell | $86.06 | 13,852 | $1,192,103.12 | 47,129 | SEC Form 4 |
Busse Falko | BRKR | PRESIDENT, BIOSPIN GROUP | Feb 28 '24 | Sell | $84.97 | 12,770 | $1,085,066.90 | 34,359 | SEC Form 4 |
Busse Falko | BRKR | PRESIDENT, BIOSPIN GROUP | Feb 28 '24 | Sell | $84.48 | 1,500 | $126,720.00 | 32,859 | SEC Form 4 |
Prause Burkhard | BRKR | PRES. & CEO, BRUKER BEST | Feb 22 '24 | Sell | $83.30 | 15,319 | $1,276,072.70 | 17,065 | SEC Form 4 |
BRKR Breaking Stock News: Dive into BRKR Ticker-Specific Updates for Smart Investing
MT Newswires
9 hours ago
Business Wire
4 days ago
Business Wire
5 days ago
Zacks
5 days ago
Zacks
6 days ago
Zacks
7 days ago
Business Wire
11 days ago
GuruFocus.com
12 days ago